发明名称 Compositions and methods to inhibit kidney stone growth
摘要 An oral dosage form or plurality of oral dosage forms comprising as active ingredients combinations of citric acid, magnesium citrate, phytin, pyridoxine, and musa is disclosed. The oral dosage form(s) is useful for inhibiting calcium oxalate crystal growth and for treating or inhibiting growth of kidney stones. Methods of inhibiting calcium oxalate crystal growth and of treating or preventing kidney stones are also disclosed.
申请公布号 US9492491(B1) 申请公布日期 2016.11.15
申请号 US201615059644 申请日期 2016.03.03
申请人 KIDNEY STONE LABORATORIES, INC. 发明人 Hayer Gregory K.;Magrab Brendan;Wolfe, Jr. Henry R.
分类号 A61K36/00;A61K36/88;A61K9/00;A61K31/194;A61K33/06;A61K31/6615;A61K31/4415;A61K9/48 主分类号 A61K36/00
代理机构 Cantor Colburn LLP 代理人 Cantor Colburn LLP
主权项 1. An oral dosage form or plurality of dosage forms comprising ingredients: magnesium citrate in an amount of about 2.03 mg to about 203 mg, phytin in an amount of about 100 mg to about 600 mg, pyridoxine in an amount of about 0.22 mg to about 15.1 mg, and musa in an amount of about 1.46 mg to about 252 mg,wherein the percent inhibition of the rate of calcium oxalate crystal formation is greater than about 99%.
地址 Fort Lauderdale FL US